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Abstract
Increased expression and/or activation of H-Ras are often associated with tumor aggressiveness in breast cancer.
Previously, we showed that H-Ras, but not N-Ras, induces MCF10A human breast epithelial cell invasion and migra-
tion, whereas both H-Ras and N-Ras induce cell proliferation and phenotypic transformation. In an attempt to deter-
mine the sequence requirement directing the divergent phenotype induced by H-Ras and N-Ras with a focus on the
induction of human breast cell invasion, we investigated the structural and functional relationships between H-Ras
and N-Ras using domain-swap and site-directed mutagenesis approaches. Here, we report that the hypervariable
region (HVR), consisting of amino acids 166 to 189 in H-Ras, determines the invasive/migratory signaling program
as shown by the exchange of invasive phenotype by swapping HVR sequences between H-Ras and N-Ras. We also
demonstrate that the H-Ras–specific additional palmitoylation site at Cys184 is not responsible for the signaling events
that distinguish between H-Ras and N-Ras. Importantly, this work identifies the C-terminal HVR, especially the flexible
linker domain with two consecutive proline residues Pro173 and Pro174, as a critical domain that contributes to
activation of H-Ras and its invasive potential in human breast epithelial cells. The present study sheds light on the
structural basis for the Ras isoform–specific invasive program of breast epithelial cells, providing information for
the development of agents that specifically target invasion-related H-Ras pathways in human cancer.
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Introduction
Ras subfamily proteins, which include H-Ras, N-Ras, and K-Ras, are
central signaling molecules that activate downstream signaling net-
works critical for cellular processes including cell survival, proliferation,
motility, and cytoskeletal organization [1]. Thus, general inhibition
of Ras activities can be detrimental not only to cancer cells but also
to normal cells. A major challenge is to develop drug compounds that
target Ras activities that are required for malignant cancer cell responses
but are less critical for normal cell functions.
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Ras expression has been suggested as amarker for tumor aggressiveness
in breast cancer [2,3]. Although mutations are rare, a single H-Ras point
mutation that changes Gly to Asp at amino acid codon 12 (G12D) has
been found in mammary carcinoma whereas the same mutation in
N-Ras is detected in teratocarcinoma and leukemia [4]. To investigate
the Ras isoform–specific signaling pathways and the subsequent cellular
responses in breast cancer, we previously established the MCF10A
human breast epithelial cell system, in which H-Ras or N-Ras is con-
stitutively activated (G12D). We have demonstrated that whereas both
H-Ras and N-Ras result in phenotypic transformation of MCF10A cells,
only H-Ras induces invasive and migratory phenotypes in these cells [5].
Induction of invasive phenotype by H-Ras, but not N-Ras, was also ob-
served in MDA-MB-453 human breast cancer cell line (unpublished
data). In theMCF10A cell system, we showed that H-Ras–induced inva-
siveness was associated with the activation of p38 mitogen-activated pro-
tein kinase (MAPK) and extracellular signal–regulated kinases (ERKs),
resulting in induction of matrix metalloproteinases 2 and 9 (MMP-2
and -9). In contrast, N-Ras failed to activate p38 MAPK, and N-Ras–
activated ERKs lead to MMP-9 induction with little effect on MMP-2
expression [6–8]. The purpose of the present study was to establish the
structural-functional relationships between H-Ras and N-Ras to unveil
the sequences of H-Ras that directs the Ras isoform–specific induction
of the invasive phenotype in human breast epithelial cells.
Whereas the four closely related Ras isoforms, H-Ras, K(A)-Ras,
K(B)-Ras, and N-Ras, share complete sequence identity in the amino-
terminal 85 amino acids and the middle 80 amino acids contain
85% homology, the carboxy-terminal hypervariable region (HVR),
which consists of residues 166 and 189, is highly divergent as depicted
in Figure 1A [1,9–12]. The HVR is composed of a flexible linker
domain (residues 167-179) and membrane-targeting or anchor domain-
containing residues 180 to 186 [13]. In order for Ras to activate the in-
tracellular signal transduction pathways mediated by growth factors and
cytokines, it must associate with the inner surface of the plasma mem-
brane [14]. Two regions in the HVR of Ras were previously suggested
to be critical for correct plasma membrane localization [15]. The first
region is a C-terminal CAAX box (in which A = aliphatic amino acid)
[16,17]. Farnesylation on the cysteine of CAAX is thought to be among
the most critical events for Ras activation [14], and the localization of
H-Ras and N-Ras is primarily determined by the CAAX motif [18].
The second region is the site for palmitoylation, necessary for
proper localization and the oncogenic activity of H-Ras [19–21].
Interestingly, H-Ras is anchored to the plasma membrane by two
palmitoylated cysteine residues, Cys181 and Cys184, whereas N-Ras
is anchored by a single cysteine, Cys181 [13,22,23].
Despite the vast amount of research on the structural and functional
properties of the Ras proteins, little is known regarding the structural
basis for H-Ras isoform–specific function in breast epithelial cells.
Here, we found that the HVR dictates H-Ras–specific signaling events
for breast epithelial cell invasion as demonstrated by swapping the
HVR sequences between H-Ras and N-Ras. We also showed that
Pro173 and Pro174 within the HVR of H-Ras are critical determi-
nants for the activation of H-Ras and H-Ras–specific invasive program
in human breast epithelial cells.
Materials and Methods
Construction of Ras Chimeras
The expression vectors encoding H-Ras (G12D), H-Ras (1-165)/
N-Ras(166-189), H-Ras (1-185)/N-Ras (CAAX), H-Ras (G184L),
N-Ras (G12D), N-Ras (1-165)/H-Ras (166-189), N-Ras (1-185)/
H-Ras (CAAX), and N-Ras (L184G) were constructed and named H,
Hn166-189, Hn186-189, Hn184, N, Nh166-189, Nh186-189, and
Nh184, respectively. The point mutants were constructed using poly-
merase chain reaction (PCR) mutagenesis on pcDNA3.1-H-Ras or
pcDNA3.1-N-Ras templates. The N-Ras/H-Ras chimeras were con-
structed using PCRmutagenesis on pcDNA3.1-N-Ras and pcDNA3.1-
H-Ras templates. The amplified DNA was ligated into the BamHI
and XhoI sites of pcDNA3.1 (Invitrogen, San Diego, CA). All of
the Ras chimeric constructs contain an oncogenic mutation at codon
12 (G12→D). Themutations were confirmed byDNA sequence analy-
sis of the plasmids before further study. MCF10A cells (5 × 105)
were placed on 6-cm-diameter culture dishes, incubated at 37°C
for 24 hours, and then transfected with 4 μg of a mutant comple-
mentary DNA (cDNA) or control vector (pcDNA3.1) for 6 hours
using Lipofectamine 2000 reagent (Invitrogen) and OPTI-MEMI re-
duced serum medium (Invitrogen). These cells were selected by G418
(500 μg/ml) for 3 weeks.
Construction of Proline Mutants
Proline mutants were constructed bymeans of the QuikChange site–
directedmutagenesis kit (Stratagene, La Jolla, CA) using the pcDNA3.1
vector containing H-Ras as a template. Pro179Gln, Pro173Ser,
Pro173Ser/Pro174Ser, and Pro173Ser/Pro174Ser/Pro179Gln (also
called PPQ, SPP, SSP, and SSQ) were mutated to exchange the proline
residues at 173, 174, and 179 to the corresponding amino acids of the
N-Ras sequence. The authenticity of all constructs was confirmed by
DNA sequencing.
Cell Culture
MCF10A and transfected cells were cultured in Dulbecco modified
Eagle medium/F12 supplemented with 5% horse serum, 0.5 μg/ml
hydrocortisone, 10 μg/ml insulin, 20 ng/ml epidermal growth factor,
0.1 μg/ml cholera enterotoxin, 100 units/ml penicillin-streptomycin,
2 mM L-glutamine, and 0.5 μg/ml amphotericin. Cells were main-
tained in a humidified atmosphere with 95% air and 5% CO2 at
37°C. Although it has been shown that the overexpression of onco-
genic H-Ras can induce a senescence-like permanent growth arrest
in several cell lines [24–26], growth inhibition was not observed in
MCF10A cells transfected with oncogenic H-Ras.
Immunoblot Analysis
Anti–N-Ras, anti–H-Ras, anti–MMP-9 antibodies were purchased
from Santa Cruz Biotechnology (Santa Cruz, CA). Anti–MMP-2 anti-
body was from R&D Systems (Minneapolis, MN). β-Actin antibody
was from Sigma-Aldrich (St Louis, MO). Anti-p38, anti–phosphorylated
p38, anti–phosphorylated MKK3/6, and anti-MKK3 antibodies were
from Cell Signaling Technology (Beverly, MA). Anti-Rac1 antibody
was from Upstate Biotechnology, Inc (Lake Placid, NY).
Equal amounts of protein extracts in SDS lysis buffer were sub-
jected to 12% SDS-PAGE analysis and electrophoretically trans-
ferred to polyvinylidene difluoride (PVDF) membranes. An enhanced
chemiluminescence (Amersham-Pharmacia, Buckinghamshire, UK)
system was used for detection. Relative band intensities were deter-
mined by quantitation of each band with an Image Analyzer (Vilber
Lourmnat, France).
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Reverse Transcription (RT)–PCR
Total RNAwas prepared using TRIzol reagent (Invitrogen, Carlsbad,
CA) according to the manufacturer’s instructions. Incubated RNA/
Oligo dT/dNTP mix was reverse-transcribed by RT-Superscript III
reverse transcriptase (Invitrogen). Thermocycler conditions were as
described previously [27].
Immunofluorescence assay. The cells (1 × 104/well) were plated at
Lab-Tek II chamber slide (Nalge Nunc International, Naperville, IL)
and then incubated for 1 day at 37°C. Cells were washed three times
with PBS and fixed in 4% formaldehyde in PBS for 20 minutes; after
washing, cells were permeabilized by treating with 0.5% Triton X-100
for 5 minutes. The fixed cells were washed again with a blocking re-
agent in PBS. The wells were incubated for 1 hour with an anti-H-Ras
or an N-Ras antibody in 1× PBS (1% BSA), washed, and then in-
cubated with anti–IgG-Alexa 488 antibody (Invitrogen, Carlsbad,
CA) for 45 minutes. After washing with 1× PBS three times for the sec-
ond labeling of cells, the cells were incubated with anti-pRac1 antibody
Figure 1. H-Ras HVR determines the invasive/migratory phenotypes of MCF10A cells. (A) Sequence alignment of H-Ras/N-Ras HVR. (B)
Schematic outline of chimera. All of the Ras constructs contain an oncogenic mutation at codon 12 (G12→D). (C, upper) Cell lysates were
collected, and Ras expression was detected by immunoblot analysis. β-Actin was used as a loading control. H-Ras activity (H-Ras–GTP) was
measured as described in Materials and Methods. (C, lower) RT-PCR analysis was performed. (D) Cells were subjected to in vitro invasion
assay and Transwell migration assay. The number of invaded or migrated cells per field was counted (×400) in 13 arbitrary visual fields. The
results represent means ± SE of triplicates. *Statistically different at P < .01, by 2-tailed Student t test.
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and, subsequently, with anti–IgG-Cy5 antibody. Confocal images were
taken in an FV-1000 spectral confocal laser scanning microscope
(Olympus, Tokyo, Japan). The fluorescence images were acquired with
FV10-ASW 1.6 Viewer (Olympus).
Gelatin Zymogram Assay
Cells were cultured in serum-free Dulbecco modified Eagle medium/
F-12 for 48 hours. Gelatinolytic activity of the conditioned medium
was determined by gelatin zymogram assay as described previously
[5]. Areas of gelatinase activity were detected as clear bands against
the blue-stained gelatin background.
In Vitro Invasion Assay and Transwell Migration Assay
In vitro invasion assays and Transwell migration assays were per-
formed using a 24-well Transwell unit as described previously [6].
Small Interfering RNA Preparation and Transfection
The small interfering RNA (siRNA) molecules targeting MMP-2,
with sequence 5′-AATACCATCGAGACCATGCGG-3′, were pur-
chased from Invitrogen (Carlsbad, CA). Nh166-189 cells were plated
in six-well plates at 1.5 × 105 cells/well, grown for 24 hours, then each
transfected with 100 pmol of siRNA for 6 hours using Lipofectamine
2000 reagent (Invitrogen) and OPTI-MEMI reduced serum medium
(Invitrogen). Control cells were treated with Stealth RNAi Negative
Control Duplex (Invitrogen).
Rac1 Activity Assay
The levels of Rac1-GTP were measured by affinity precipitation
using PAK-1 p21-binding domain Rac assay reagent (Upstate Bio-
technology) following the manufacturer’s instructions as previously
described [7].
H-Ras Activity Assay
The levels of H-Ras–GTP were measured by affinity precipitation
using Raf-1 RBD Ras assay reagent (Upstate Biotechnology) follow-
ing the manufacturer’s instructions. Briefly, cells were lysed in MLB
buffer, and Raf-1 RBD-agarose was immediately added to the cell
lysate and incubated for 45 minutes at 4°C. The bead pellet was
washed three times with MLB buffer. The bead pellet was finally sus-
pended in Laemmli sample buffer. Proteins were separated by 12%
SDS-PAGE, transferred to nitrocellulose membranes, and blotted
with anti–H-Ras antibody following the manufacturer’s instructions.
Results
H-Ras HVR Determines the Invasive and Migratory
Phenotypes in MCF10A Cells
To study the molecular mechanism underlying the H-Ras–specific
migratory/invasive phenotypes in human breast epithelial cells, we
wished to determine the structural-functional properties of H-Ras
and N-Ras proteins. Because the amino acid sequences of H-Ras
and N-Ras greatly differ in the 166 to 189 HVR (Figure 1A), we
tested whether this region is a major contributor to H-Ras–specific
signaling for human breast epithelial cell invasion. To this end, we
generated chimeric constructs, Hn166-189 and Nh166-189. As de-
picted in Figure 1 (A and B), Hn166-189 represents a chimera,
which is composed of the H-Ras amino acid sequences from 1 to
165 fused to the N-Ras HVR (amino acid residues 166-189). Sim-
ilarly, Nh166-189 contains residues 1 to 165 of N-Ras fused to the
H-Ras HVR (residues 166-189). The stable expression of these chi-
mera in MCF10A cells was confirmed by immunoblot analysis using
antibodies against pan-Ras, H-Ras HVR, or N-Ras HVR (Figure 1C ,
upper) and by RT-PCR analysis (Figure 1C , lower). Importantly, the
active form of H-Ras (H-Ras–GTP) was markedly decreased in
MCF10A cells transfected with Hn166-189 compared with H-Ras
MCF10A cells. Because the anti–H-Ras antibody used in this study
recognizes the C-terminal region of H-Ras, the Hn166-189 showed
decreased levels of both active H-Ras and total H-Ras compared with
the wild-type H-Ras. Conversely, we observed a marked increase in
Figure 1. (continued).
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the level of active H-Ras in Nh166-189 cells. These data demon-
strate that the HVR is crucial for the activation of H-Ras.
When the effects of chimera protein expression on cell invasion/
migration were examined, Hn166-189 drastically reduced the ability
of H-Ras to induce invasive and migratory properties in MCF10A
cells (Figure 1D and Figure W1). More interestingly, Nh166-189
induced cell invasion and migration as effectively as H-Ras. Similar
results were obtained using additional clones expressing chimera con-
structs (data not shown). These results showed that H-Ras HVR is a
critical determinant for the ability of Ras to induce cell invasion and
migration in human breast epithelial cells.
Neither the H-Ras–Specific CAAX Motif nor the H-Ras–Specific
Palmitoylation Site Alone Plays a Critical Role for
H-Ras–Specific Signaling for Cell Invasion/Migration
Mounting evidence has suggested a crucial role for the CAAX
motif of Ras proteins in plasma membrane targeting and subsequent
activation of intracellular signal transduction pathways [14,28]. Next,
Figure 2. H-Ras HVRs are critical for the activation of the Rac-MKK3/6-p38 pathway. (A) For Rac1 activity, cell lysates were incubated with
GST-PBD fusion protein, and the bound active Rac1-GTPmolecules were analyzed by immunoblot analysis using an anti-Rac1 antibody. The
levels of activated MKK3/6, p38 in Ras chimera, and mutant cells were determined by immunoblot analysis of whole cell lysates. Band
intensities were quantitated and plotted. *,**Statistically different at P < .05 and P < .01, respectively. (B) Cells were double labeled for
H-Ras or N-Ras (green) and pRac1 (red). Immunocytochemical colocalization of H-Ras or N-Ras and flotillin-1 was observed by confocal
microscopy. (C) H-Ras MCF10A cells were transfected with control siRNA or siRNA H-Ras. Protein level of H-Ras was detected by immuno-
blot analysis. β-Actin was used as a loading control. Rac1 activity (Rac1-GTP) was measured as described in Materials and Methods.
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we examined whether difference in the CAAX sequences between
H-Ras and N-Ras contributes to the differential ability to regulate cell
invasion/migration. To this end, we generated two Ras mutants,
Hn186-189 and Nh186-189, which represent a H-Ras mutant con-
taining the N-Ras CAAX motif (CVVM at amino acid sequences
186-189) and a N-Ras mutant containing the H-Ras CAAX motif
(CVLS), respectively (Figure 1, A and B). Exchange of the CAAX motif
between the two Ras isoforms did not alter the level of H-Ras–GTP
(Figure 1C ) or the invasive/migratory properties of H-Ras and N-Ras
(Figure 1D). These data indicate that as long as the farnesylatable site
at C186 of CAAX is maintained, the mutation of Ras isoform–specific
CAAX motif did not affect the induction of the H-Ras–specific sig-
naling events.
In addition to the CAAX motif, palmitoylation of Ras affects mem-
brane targeting and retention, thereby regulating the intrinsic signaling
capacity of Ras proteins [19–21]. Whereas H-Ras is palmitoylated on
two cysteines (Cys181 and Cys184), N-Ras has a single palmitoylation
site at Cys181. We next questioned whether the additional palmitoyla-
tion site at 184 in H-Ras plays a role in H-Ras–specific induction of
cell migration or invasion. To address this, we performed site-directed
mutagenesis and generated an H-Ras mutant (Hn184) in which
Cys184, the second palmitoylation site, was mutated to Leu, resulting
the Cys181 monopalmitoylated H-Ras. Similarly, we also generated
an N-Ras mutant (Nh184) in which Leu184 was mutated to Cys (Fig-
ure 1, A and B). Neither the loss of the second palmitoylation site in
H-Ras nor the gain of a potential palmitoylation site in N-Ras affected
the level of active H-Ras (H-Ras–GTP; Figure 1C ) or the invasive/
migratory potentials caused by H-Ras and N-Ras (Figure 1D). These
results demonstrate that monopalmitoylation of Cys181 of H-Ras is
sufficient for its activation and the induction of invasive/migratory
Figure 2. (continued).
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phenotypes, suggesting that the sequence difference between H-Ras
and N-Ras in the additional palmitoylation site at Cys184 may not
be responsible for their different effects on human breast epithelial cell
migration and invasion.
HVR Is Critical for Activation of the Rac-MKK3/6-p38
Pathway and MMP-2 Up-regulation
We have previously shown that H-Ras, but not N-Ras, activates the
Rac-MKK (MAP kinase kinase) 3/6-p38 pathway, leading to the invasive/
migratory phenotype [7]. Here, we further examined how the Ras
isoform–specific signaling program is affected by the H-Ras/N-Ras
chimeras as well as the H-Ras/N-Ras CAAX and palmitoylation site
mutants. As shown in Figure 2A, active Rac1 (Rac1-GTP) and phos-
phorylated forms of MKK3/6 and p38 were significantly reduced
in MCF10A cells transfected with Hn166-189 compared with the
H-Ras MCF10A cells. Conversely, we observed a marked increase
in the levels of active Rac1 and phosphorylated MKK3/6 and p38
in Nh166-189 cells. Also consistent with the results of H-Ras activa-
tion and cell migration/invasion, neither the CAAX mutants Hn186-
189 and Nh166-189 nor the palmitoylation site mutants Hn184 and
Nn184 showed detectable changes in the activation of Rac1, MKK3/6,
or p38. To investigate if localization of H-Ras actually correlates with
the activation of Rac1, colocalization of H-Ras, and phospho-Rac1
(pRac1) was examined by confocal microscopy. As shown in Figure 2B
(upper), H-Ras colocalized with pRac1 in MCF10A cells transfected
with H-Ras and Nh166-189. In contrast, colocalization of N-Ras
and pRac1 was barely detected in MCF10A cells transfected with
N-Ras and Hn166-189 (Figure 2B, lower). These data indicate that
the localization of H-Ras actually correlates with the activation of
Rac1 in which H-Ras HVR plays a critical role. To examine if the
increase of Rac1 activation in H-Ras MCF10A cells is due to the in-
crease in total H-Ras levels, we knocked down H-Ras expression using
an siRNA targeting H-Ras. As shown in Figure 2C , the active form
of Rac1 was significantly reduced by siRNA knockdown of H-Ras,
indicating that H-Ras is critical for the activation of Rac1 in H-Ras
MCF10A cells.
Because our previous studies revealed that MMP-2 up-regulation
by H-Ras is critical for H-Ras–mediated MCF10A cell invasion and
migration [6,8], we next examined the effects of the H-Ras/N-Ras
chimeras on MMP-2 expression. As shown in Figure 3A, the ability
of H-Ras to induce MMP-2 expression was decreased in Hn166-
189, whereas Hn186-189 and Hn184 induced MMP-2 as much or
only slightly less than H-Ras. Nh166-189, but not Nh186-189 or
Nh184, was observed to induce MMP-2 (Figure 3B). These results
demonstrate that the HVR of H-Ras is a major contributor to the reg-
ulation of H-Ras–specific signaling that leads to MMP-2 up-regulation
in MCF10A cells. These results also indicate that the CAAX motif and
the palmitoylation sites of H-Ras and N-Ras are not important for
H-Ras–specific MMP induction in these cells.
To confirm the functional significance of MMP-2 up-regulation in
cell invasion and migration induced by Nh166-189, we knocked
down MMP-2 expression using a siRNA targeting MMP-2 mRNA.
The expression of MMP-2 was efficiently reduced by this approach,
as evidenced by gelatin zymogram assay and immunoblot analysis
(Figure 3C ). Nh166-189–induced invasion and migration were both
significantly inhibited by siRNA knockdown of MMP-2 (Figure 3D),
indicating that MMP-2 is a critical mediator of MCF10A cell invasion/
migration by H-Ras signaling in its HVR-specific manner.
The Proline-Rich Motif in the Linker Domain of H-Ras
Is Critical for H-Ras–Induced Human Breast Epithelial
Cell Invasion
The flexible linker domain of the H-Ras HVR is enriched for proline
residues (Pro173, Pro174, and Pro179), whereas the corresponding
amino acids in N-Ras are Ser173, Ser174, and Gln179 (Figure 1A).
Because the proline-rich motifs have been frequently found in the hinge
region and thus have been shown to play a crucial role in protein fold-
ing [29–32], we examined the functional significance of these proline
residues in H-Ras–specific regulation of breast epithelial cell invasion
and migration. To this end, we generated five H-Ras mutants, SPP,
PSP, PPQ, SSP, and SSQ, in which each proline residue (P) at positions
173, 174, or 179 of H-Ras was substituted by the corresponding amino
acid present in N-Ras, serine (S) or glutamine (Q), as depicted in
Figure 4A. The level of active H-Ras (H-Ras–GTP) was measured in
MCF10A cells expressing the wild-type (PPP) and the mutant H-Ras
proteins. SSP and SSQ, in which the proline residues at 173 and 174
are replaced by serine residues, significantly decreased H-Ras–GTP
levels (Figure 4B), demonstrating that Pro173 and Pro174 are required
for the activation of H-Ras in breast epithelial cells.
Active Rac1 (Rac1-GTP), which is activated in a H-Ras–specific
manner [7], was also significantly decreased in cells expressing the
SSP and SSQ mutants compared with wild-type H-Ras (Figure 4C).
Importantly, whereas the SSP and SSQ mutants significantly reduced
the invasive and migratory abilities of the cells, the SPP, PSP, and PPQ
mutants, in which only one proline residue is mutated, did not sig-
nificantly inhibit invasion/migration compared with wild-type H-Ras
(Figure 4D). Of note, although the SSQ mutant showed a near-
complete decrease in H-Ras–GTP, only 40% to 50% inhibition of
invasion and migration was observed. Given that invasive/migratory
phenotypic changes are complex multistep processes and their genetic
and biochemical determinants are still largely unknown, it would be
worthwhile to further elucidate the multiple factors other than H-Ras,
which are involved in these processes.
We next investigated the invasiveness of two mutant N-Ras con-
structs, N-Ras(PPQ) and N-Ras(PPP), in which amino acid residues
173, 174, and 179 of N-Ras were substituted to proline. Invasive
phenotype was not significantly induced by these mutants (data not
shown), indicating that the replacement of amino acid residues 173,
174, and 179 to proline was not sufficient to confer the invasive ability
to N-Ras. These data indicate that the consecutive proline residues of
H-Ras HVR, Pro173 and Pro174, are essential for H-Ras activity and
its induction of invasive/migratory phenotypes in MCF10A cells.
Discussion
Ras is a central signaling molecule that regulates oncogenesis and
metastasis of breast cancer. H-Ras and N-Ras differentially regulate
the invasive and migratory properties of breast epithelial cells, which
led us to investigate which portions of the amino acid sequence are
required for H-Ras–specific functions. Here we demonstrate that
the HVR, consisting of amino acids 166 to 189 of H-Ras, is essential
for H-Ras–specific signaling to induce the invasive phenotype. Con-
sistent with our finding, it has been shown that the HVR of H-Ras
is important for its activities [19,33–35]. Similarly to the HVR of
H-Ras, the HVR of R-Ras (amino acids 178-218) plays an important
role in R-Ras signal transduction and regulation of the morphology
and motility of MCF10A cells [36–38]. The present study not only
underscores the importance of HVR for H-Ras functions but also
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reveals a critical role for HVR as a determinant for differences between
H-Ras and N-Ras specific signaling events. The present study for the
first time shows that noninvasive N-Ras can mediate breast cell invasion
if its HVR sequences are replaced with those of H-Ras, whereas H-Ras’
ability to induce cell invasion is abolished by the N-Ras HVR se-
quences. Because the HVR sequences of K-Ras greatly differ from those
of H-Ras and N-Ras [39], it would be of interest to further investigate
the effect of K-Ras HVR on the breast cell invasion.
The localization of H-Ras and N-Ras is primarily determined by
the CAAX motif [18] and the presence and position of the palmitoyl
groups [39]. Distinct roles of two palmitoyl residues in H-Ras have
been demonstrated; whereas monopalmitoylation of Cys181 is re-
quired and sufficient for efficient trafficking of H-Ras from the Golgi
apparatus to the plasma membrane, monopalmitoylation of Cys184
supports correct GTP-regulated lateral segregation of H-Ras between
microdomains in the membrane [20]. To our surprise, our data show
that the loss of second palmitoylation site at amino acid residue 184
did not play a critical role for H-Ras activation and H-Ras–induced
specific signaling events, which is inconsistent with the previously sug-
gested role of Cys184 in H-Ras microlocalization and activation [20].
Our findings implicate that monopalmitoylation of Cys181 of H-Ras is
sufficient for the H-Ras activation and subsequent cellular responses.
In the HVR of H-Ras, there are three proline residues at positions
173, 174, and 179, whereas N-Ras lacks a proline residue at all of these
positions. Pro173 and Pro174 are extensively conserved among species
(National Center for Biotechnology Information, http://www.ncbi.
nlm.nih.gov/pubmed/), implying that these residues may be important
for H-Ras function. Proline-rich sequences, often found in the hinge
regions, are known to restrict the conformation of the protein and play
an indispensable role in the regulation of various cellular responses. For
instance, the proline-rich motifs are important for delivering actin
monomers to specific cellular locations where membrane protrusions
necessary for cell motility are formed [40]. A recently identified colon
cancer–associated gene product, MACC1, induces proliferation and
invasion through its proline-rich motif and thereby promotes colon
cancer metastasis [41]. Similar to H-Ras, R-Ras contains a polyproline
site in the HVR that is required for R-Ras–induced integrin activation
[42]. In the present study, we provide evidence suggesting a critical role
of the proline-rich motif of the flexible linker domain in the H-Ras
HVR for H-Ras activation.
Figure 3. H-Ras HVR are necessary for MMP-2 up-regulation. (A, B) Conditioned media were collected and analyzed for expression of
MMP-2 and MMP-9 by gelatin zymogram assay (upper) and immunoblot analysis (lower). (C) Knockdown of MMP-2 by siRNA was con-
firmed by gelatin zymography and immunoblot analysis in Nh166-189 cells. Control cells were treated with Stealth RNAi Negative Con-
trol Duplexes. (D) Cells transfected with siRNA targeting MMP-2 was subjected to an in vitro invasion assay (left panel) or a Transwell
migration assay (right panel). The number of invaded or migrated cells per field was counted (×400) in 13 arbitrary visual fields. The results
represent means ± SE of triplicates. *Statistically different from control at P < .01.
Neoplasia Vol. 13, No. 2, 2011 H-Ras–Specific Motif for its Activation Yong et al. 105
The three-dimensional structure of the soluble part of H-Ras, com-
prising the amino-terminal 166 residues, has been determined by x-ray
crystallography [43]. However, the structure of the membrane-bound
HVR of H-Ras is not presently available. Because the three-dimensional
structural analysis of the H-Ras HVR has not yet been completed, we
can only speculate the potential structural difference between wild-type
H-Ras (Pro173/Pro174) and a mutant H-Ras (Ser173/Ser174) proteins
and its implication in the regulation of intracellular signal transduction
pathways. On the basis of modeling and molecular dynamics simu-
lations of a protein structure for full-length H-Ras in complex with a
1,2-dimyristoylglycero-3-phosphocholine bilayer [12], we propose
computational protein structure models of wild-type H-Ras (Pro173/
Pro174) and a mutant H-Ras (Ser173/Ser174) as shown in Figure W2.
The predicted mutant structure displayed noticeable changes in the
HVR, especially in the orientation of the loop containing residues
176 to 182, known to interact with the membrane. This subtle dif-
ference may be critical for the activation of H-Ras–specific signal trans-
duction. The structural-functional relationship of H-Ras and the exact
molecular mechanisms by which H-Ras induces breast cell invasion
awaits the completion of three-dimensional structural analysis of H-Ras
that includes the membrane-bound HVR.
This study demonstrated that the HVR (166-189) of H-Ras, especi-
ally Pro173 and Pro174, plays a critical role in the activation of H-Ras
and H-Ras–specific induction of mammary cell invasion/migration.
The present study sheds light on the structural basis underlying the
Ras isoform-specific invasive program of breast epithelial cells. It also
provides a rationale for the development of agents that specifically target
invasion-related Ras pathways, which may have broad implications in
breast cancer.
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Figure W1. Cells were subjected to in vitro invasion assay and Transwell migration assay. The abilities to invasion and migration were
assessed using an inverted phase-contrast microscope (original magnification, ×400).
Figure W2. Proposed computational protein structure models of H-Ras proteins. The structures of wild-type H-Ras (left, blue) and a mu-
tant H-Ras (Ser173/Ser174, center, red) were modelled using ModWeb (a server for protein structure modeling, version SVN. r1278) and
MODELLER 9v7. The structural images were produced using the PyMOL program.
